TRICOG HEALTH INDIA PRIVATE LIMITED

Business Overview

• Tricog Health India Pvt Ltd is an AI-powered cardiac-diagnostics company founded in 2014 by Dr.
• Charit Bhograj, interventional cardiologist.
• It operates a tele-cardiology network combining AI-based ECG interpretation software with a 24x7 remote cardiologist reporting service, deployed across a stated 5,000+ hospitals, cath labs, clinics and diagnostic centres in India and select overseas markets.
• Clients/partners referenced on its own site include Apollo, Fortis, Manipal, Max Healthcare, Metropolis, Medall, Vijaya Diagnostics, Neuberg, Redcliffe Labs, and several state governments, Goa, Telangana, Maharashtra, Odisha., Source: company website tricog.com, TheCompanyCheck

Sector & Classification

Healthcare / Diagnostic services — Hospital and medical care activities; also classified under Computer programming & consultancy (Source: Tofler, TheCompanyCheck). DPIIT-recognised startup.

Directors & Key Management

GST Registrations

Primary GSTIN: 29AAGCT4928D1Z6 (Karnataka), registered 21 Feb 2019, entity "Tricog Health India Private Limited," address matches registered office (Old No.82/New No.3, Vyalikaval, Bengaluru 560003). PAN embedded in GSTIN (AAGCT4928D) matches PAN from Tofler — cross-check consistent. Home state: Karnataka. Number of registrations found: 1 (no evidence of multi-state registration found). Status: appears active per aggregator listings (knowyourgst.com, mastersindia.co, and other GST aggregators). CAUTION — entity-confusion trap: a similarly named GROUP entity "Tricog Health Services Pvt Ltd" has its own separate GSTIN 29AAFCT0932N1ZY and separate PAN (AAFCT0932N) — this is NOT the target company's GSTIN and is reported here only to flag the distinction, not attributed to the target.

Financials

• FY2025, year ended 31 Mar 2025, revenue: ₹77.68 crore, up ~25% YoY, Source: TheCompanyCheck, corroborated in figure by Tracxn's public snippet ~₹77.7 Cr, — confirmed.
• EBITDA, PAT and net worth for FY2025: locked/not disclosed by TheCompanyCheck — not obtained.
• Last filed financials/AGM per registry trail: year ended 31 Mar 2024, AGM 09 Sep 2024.
• Statement basis: standalone, Indian entity only; excludes Tricog Health Pte Ltd or Tricog Health Services Pvt Ltd.
• CONFLICT NOTE: a separate web source, Inc42-attributed snippet, suggested FY2024 revenue ₹9.0 Cr and PAT ₹2.6 Cr, which is inconsistent with TheCompanyCheck's implied FY2024 base, ~₹62 Cr, back-calculated from the stated 25% YoY growth to ₹77.68 Cr in FY25.
• This Inc42 figure could not be independently verified and may reflect a different entity/fiscal year — treat as unconfirmed/likely erroneous rather than authoritative.
• Auditor: S Dutta & Co, Source: TheCompanyCheck.

Funding History

• Tricog Health (group) is reported at Series B stage with cumulative funding roughly in the $23–30M range across multiple rounds, Source: Tracxn public snippet, DuckDuckGo aggregation, — not independently itemized.
• One specific round is corroborated: ~$8.5 million (~₹70 crore) announced around April 2023, led by Omron Healthcare (Japan) and Sony Innovation Fund (Japan), with participation from University of Tokyo Edge Capital (UTEC), Inventus Partners, and SG Innovate (Singapore), Source: company/press announcement, corroborated by search aggregation.
• A further/second Omron Healthcare investment was reported around 12 Nov 2025 "to advance AI-powered cardiac care in India", Source: press aggregation, — exact amount not obtained.
• Full round-by-round history, seed, Series A, etc., with dates/amounts, not obtained — partial only.

Shareholding

• Not obtained at the target-entity level with verifiable percentages.
• TheCompanyCheck indicates Tricog Health India Pvt Ltd is a subsidiary of Tricog Health Pte Ltd, Singapore, likely the funding/holding entity for the group.
• A figure of "67.75% public holding (2023)" appearing in search snippets is attributed to the DIFFERENT entity "Tricog Health Services" and is NOT attributed here to the target CIN, per entity-confusion caution — flagged, not used.
• Cap-table/investor-wise stake data not accessible, locked behind Tracxn/Inc42 Datalabs paid tiers.

Loans & Charges

• Open charges: ₹14.89 crore total — SIDBI ₹6.00 crore
• Other lenders ₹8.89 crore. Satisfied charges: ₹0 reported., Source: TheCompanyCheck. Not cross-verified against a second source — treat as partial/single-source.

Related Parties

• Parent: Tricog Health Pte Ltd (Singapore) — per TheCompanyCheck, "subsidiary of Tricog Health Pte Ltd".
• Sister/group entity found in GST data: Tricog Health Services Pvt Ltd, GSTIN 29AAFCT0932N1ZY, PAN AAFCT0932N, registered 01 Jul 2017, — a DIFFERENT legal entity from the target CIN
• Its financials/GSTIN/shareholding must not be merged with the target's. No other related-party/group entities confirmed.

Competitive Landscape

• AliveCor, US, personal/clinical AI-ECG devices — larger global scale
• Agatsa/SanketLife, India, portable ECG device maker — smaller/early-stage
• Eko Health, US, AI-enabled digital stethoscopes — mid-size, well-funded
• Cardiologs, France/US, AI ECG interpretation software, acquired by Philips — larger, strategic-backed
• Domestic tele-diagnostics/remote-monitoring peers such as Dozee and Portea Medical operate in adjacent remote cardiac/vitals monitoring space, broader scale, different core product. Scale tags are approximate/directional, not audited.

Frequently Asked Questions